دورية أكاديمية
أعرض في EDS

Dynamic Role of miRNAs in Salivary Gland Carcinomas: From Biomarkers to Therapeutic Targets.

التفاصيل البيبلوغرافية
العنوان: Dynamic Role of miRNAs in Salivary Gland Carcinomas: From Biomarkers to Therapeutic Targets.
المؤلفون: Kimura TC; Department of Oral Diagnosis, Piracicaba Dental School, State University of Campinas (UNICAMP), Piracicaba, Brazil.; Department of Pathology, School of Medical Sciences, State University of Campinas (UNICAMP), Campinas, Brazil., de Lima-Souza RA; Department of Oral Diagnosis, Piracicaba Dental School, State University of Campinas (UNICAMP), Piracicaba, Brazil.; Department of Pathology, School of Medical Sciences, State University of Campinas (UNICAMP), Campinas, Brazil., Maciel TF; Department of Oral Diagnosis, Piracicaba Dental School, State University of Campinas (UNICAMP), Piracicaba, Brazil.; Department of Pathology, School of Medical Sciences, State University of Campinas (UNICAMP), Campinas, Brazil., Kowalski LP; Department of Head and Neck Surgery and Otorhinolaryngology, A.C. Camargo Cancer Center, São Paulo, Brazil., Coutinho-Camillo CM; International Research Center, A.C.Camargo Cancer Center, São Paulo, Brazil., Egal ESA; Department of Pathology, School of Medical Sciences, State University of Campinas (UNICAMP), Campinas, Brazil.; Biorepository and Molecular Pathology, Huntsman Cancer Institute, University of Utah (UU), Salt Lake City, Utah, USA., Altemani A; Department of Pathology, School of Medical Sciences, State University of Campinas (UNICAMP), Campinas, Brazil., Mariano FV; Department of Pathology, School of Medical Sciences, State University of Campinas (UNICAMP), Campinas, Brazil. fevimariano@gmail.com.
المصدر: Head and neck pathology [Head Neck Pathol] 2024 Feb 23; Vol. 18 (1), pp. 12. Date of Electronic Publication: 2024 Feb 23.
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: Country of Publication: United States NLM ID: 101304010 Publication Model: Electronic Cited Medium: Internet ISSN: 1936-0568 (Electronic) Linking ISSN: 1936055X NLM ISO Abbreviation: Head Neck Pathol Subsets: MEDLINE
أسماء مطبوعة: Publication: June 2011- : New York : Springer Science+ Business Media
Original Publication: Secaucus, NJ : Humana Press
مواضيع طبية MeSH: MicroRNAs*/genetics , Salivary Gland Neoplasms*/pathology , Carcinoma*, Humans ; Biomarkers ; Carcinogenesis/genetics ; Cell Transformation, Neoplastic ; Prognosis ; Salivary Glands/metabolism ; Biomarkers, Tumor/genetics
مستخلص: Background: Salivary gland carcinomas (SGCs) are a rare group of malignant neoplasms of the head and neck region. MicroRNAs (miRNAs) are a class of small non-coding RNAs that have been associated with the control biological process and oncogenic mechanism by the regulation of gene expression at the post-transcriptional level. Recent evidence has suggested that miRNA expression may play a role in the tumorigenesis and carcinogenesis process in SGCs.
Methods: This review provides a comprehensive literature review of the role of miRNAs expression in SGCs focusing on the diagnostic, prognostic, and therapeutic applications.
Results: In this review, numerous dysregulated miRNAs have demonstrated an oncogenic and suppressor role in SGCs.
Conclusion: In the future, these miRNAs may eventually constitute useful diagnostic and prognostic biomarkers that may lead to a better understanding of SGCs oncogenesis. Additionally, the development of therapeutic agents based on miRNAs may be a promising target in SGC treatment.
(© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
References: PLoS One. 2019 Jan 25;14(1):e0210968. (PMID: 30682201)
Int J Oncol. 2020 Aug;57(2):574-586. (PMID: 32467999)
Eur Rev Med Pharmacol Sci. 2017 Jan;21(1):120-130. (PMID: 28121346)
Biochim Biophys Acta. 2013 Nov;1830(11):5258-66. (PMID: 23911747)
Head Neck Pathol. 2019 Sep;13(3):344-354. (PMID: 30259272)
Sci Rep. 2022 Aug 4;12(1):13383. (PMID: 35927424)
Asian Pac J Cancer Prev. 2014;15(21):9071-5. (PMID: 25422181)
Mol Biol Rep. 2022 Mar;49(3):2157-2167. (PMID: 34981333)
Cell Death Dis. 2018 Sep 11;9(9):917. (PMID: 30206227)
Cells. 2019 Jul 25;8(8):. (PMID: 31349668)
Cell Signal. 2023 Sep;109:110748. (PMID: 37290676)
Head Neck Pathol. 2022 Dec;16(4):1134-1145. (PMID: 35980523)
Int J Mol Sci. 2021 Jun 29;22(13):. (PMID: 34209954)
Adv Exp Med Biol. 2020;1253:3-55. (PMID: 32445090)
Gene. 2018 Dec 15;678:349-360. (PMID: 30098429)
PLoS One. 2014 Nov 04;9(11):e111877. (PMID: 25369070)
Pathol Res Pract. 2022 Oct;238:154119. (PMID: 36137399)
Mol Cell Biochem. 2021 Feb;476(2):1269-1282. (PMID: 33237453)
Carcinogenesis. 2022 Aug 30;43(7):682-692. (PMID: 35380635)
Sci Rep. 2016 Feb 08;6:20616. (PMID: 26852921)
Pathol Res Pract. 2017 Dec;213(12):1470-1476. (PMID: 29108921)
Nat Rev Drug Discov. 2017 Mar;16(3):203-222. (PMID: 28209991)
Oral Oncol. 2014 Aug;50(8):683-90. (PMID: 24856188)
Future Oncol. 2012 Nov;8(11):1407-25. (PMID: 23148615)
Virchows Arch. 2018 Sep;473(3):329-340. (PMID: 30069755)
Biochem Biophys Res Commun. 2018 Jun 7;500(3):632-638. (PMID: 29678584)
Mol Med Rep. 2018 Mar;17(3):4237-4244. (PMID: 29328455)
Cell Mol Life Sci. 2018 Oct;75(19):3539-3551. (PMID: 30030592)
Biomed Pharmacother. 2018 Sep;105:1054-1061. (PMID: 30021341)
Braz J Otorhinolaryngol. 2017 May - Jun;83(3):276-284. (PMID: 27184509)
Jpn J Clin Oncol. 2017 Aug 01;47(8):690-698. (PMID: 28591777)
Hum Pathol. 2017 Aug;66:10-12. (PMID: 28583885)
Mol Ther. 2018 Dec 5;26(12):2766-2778. (PMID: 30217729)
Clin Res Hepatol Gastroenterol. 2016 Nov;40(5):538-545. (PMID: 27179559)
Mod Pathol. 2018 Aug;31(8):1211-1225. (PMID: 29467480)
Oncogene. 2008 Apr 3;27(15):2128-36. (PMID: 17968323)
Front Oncol. 2022 Feb 09;11:786150. (PMID: 35223452)
Am J Cancer Res. 2015 Sep 15;5(10):3015-29. (PMID: 26693056)
J Oral Pathol Med. 2013 Feb;42(2):140-7. (PMID: 22823535)
Clin Exp Dent Res. 2023 Feb;9(1):112-121. (PMID: 36281584)
Biotechnol Lett. 2016 Mar;38(3):409-16. (PMID: 26687302)
Virchows Arch. 2017 Mar;470(3):291-299. (PMID: 27981346)
BMC Cancer. 2014 Dec 10;14:930. (PMID: 25496077)
PLoS One. 2013 Jun 25;8(6):e66778. (PMID: 23825564)
Oral Dis. 2018 May;24(4):537-543. (PMID: 29095552)
Biomed Res Int. 2017;2017:9150402. (PMID: 28377929)
Oral Maxillofac Surg. 2021 Dec;25(4):445-456. (PMID: 33666770)
Head Neck. 2022 Feb;44(2):505-517. (PMID: 34862810)
Hum Cell. 2021 Jul;34(4):1185-1196. (PMID: 33813728)
Anticancer Res. 2017 Jul;37(7):3473-3481. (PMID: 28668836)
Oncotarget. 2014 Dec 30;5(24):12528-42. (PMID: 25587024)
Lab Invest. 2015 Dec;95(12):1398-408. (PMID: 26367487)
Mol Med Rep. 2013 Feb;7(2):708-12. (PMID: 23232714)
Mol Cancer. 2015 Apr 29;14:96. (PMID: 25924850)
Cancer Cell Int. 2019 Nov 16;19:301. (PMID: 31762692)
Anticancer Res. 2015 Mar;35(3):1271-7. (PMID: 25750274)
Oral Dis. 2022 Oct;28(7):1871-1881. (PMID: 33694237)
Biol Rev Camb Philos Soc. 2009 Feb;84(1):55-71. (PMID: 19046400)
Am J Transl Res. 2017 Mar 15;9(3):1101-1113. (PMID: 28386337)
J Oral Pathol Med. 2019 Oct;48(9):840-845. (PMID: 31165496)
Cell Death Dis. 2014 May 22;5:e1246. (PMID: 24853424)
Mol Ther Nucleic Acids. 2020 Jun 5;20:409-420. (PMID: 32244168)
Int J Clin Exp Med. 2015 Sep 15;8(9):14759-63. (PMID: 26628958)
J Oral Pathol Med. 2022 Feb;51(2):160-171. (PMID: 34797582)
فهرسة مساهمة: Keywords: Diagnostic; MicroRNAs; Prognosis; Salivary gland neoplasms; Therapy
المشرفين على المادة: 0 (MicroRNAs)
0 (Biomarkers)
0 (Biomarkers, Tumor)
تواريخ الأحداث: Date Created: 20240223 Date Completed: 20240226 Latest Revision: 20240227
رمز التحديث: 20240227
مُعرف محوري في PubMed: PMC10891027
DOI: 10.1007/s12105-023-01603-4
PMID: 38393615
قاعدة البيانات: MEDLINE
الوصف
تدمد:1936-0568
DOI:10.1007/s12105-023-01603-4